Panbela announces publication of clinical data titled: phase 1 study of high-dose dfmo, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a new approaches to neuroblastoma therapy trial

A phase 1 clinical study showed that high dose dfmo treatment in combination with chemotherapy may provide therapeutic benefits to heavily pretreated patients with neuroblastoma. a phase 1 clinical study showed that high dose dfmo treatment in combination with chemotherapy may provide therapeutic benefits to heavily pretreated patients with neuroblastoma.
PBLA Ratings Summary
PBLA Quant Ranking